Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized colistin sulfate dosing in carbapenem-resistant Gram-negative bacilli infection based on population pharmacokinetics
ChiCTR2300072191Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- May 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of colistin, sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoints: Plasma concentration of colistin sulfate and Pharmacokinetic parameters of colistin sulfate. Started May 2023; status: recruiting.
02
Drugs
colistin
Beyond the preview
Go deeper on ChiCTR2300072191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072191.